Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion
Trivellin, G.; Daly, A. F.; Hernandez-Ramirez, L. C.; Araldi, E.; Tatsi, C.; Dale, R. K.; Fridell, G.; Mittal, A.; Faucz, F. R.; Iben, J. R.; Li, T.; Vitali, E.; Stojilkovic, S. S.; Kamenicky, P.; Villa, C.; Baussart, B.; Chittiboina, P.; Toro, C.; Gahl, W. A.; Eugster, E. A.; Naves, L. A.; Jaffrain-Rea, M.-L.; de Herder, W. W.; Neggers, S. J.; Petrossians, P.; Beckers, A.; Lania, A. G.; Mains, R. E.; Eipper, B. A.; Stratakis, C. A.
Show abstract
Pituitary adenomas (PAs) are common, usually benign tumors of the anterior pituitary gland which, for the most part, have no known genetic cause. PAs are associated with major clinical effects due to hormonal dysregulation and tumoral impingement on vital brain structures. Following the identification of a loss-of-function variant (p.Arg703Gln) in the PAM gene in a family with pituitary gigantism, we investigated 299 individuals with sporadic PAs and 17 familial isolated pituitary adenomas kindreds for PAM variants. PAM encodes a multifunctional protein responsible for the essential C-terminal amidation of secreted peptides. Genetic screening was performed by germline and tumor sequencing and germline copy number variation (CNV) analysis. No germline CNVs or somatic single nucleotide variants (SNVs) were identified. We detected seven likely pathogenic heterozygous missense, truncating, and regulatory SNVs. These SNVs were found in sporadic subjects with GH excess (p.Gly552Arg and p.Phe759Ser), pediatric Cushing disease (c.-133T>C and p.His778fs), or with different types of PAs (c.-361G>A, p.Ser539Trp, and p.Asp563Gly). The SNVs were functionally tested in vitro for protein expression and trafficking by Western blotting, for splicing by minigene assays, and for amidation activity in cell lysates and serum samples. These analyses confirmed a deleterious effect on protein expression and/or function. By interrogating 200,000 exomes from the UK Biobank, we confirmed a significant association of the PAM gene and rare PAM SNVs to diagnoses linked to pituitary gland hyperfunction. Identification of PAM as a candidate gene associated with pituitary hypersecretion opens the possibility of developing novel therapeutics based on altering PAM function.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Stretch-activated ion channel TMEM63B associates with developmental and epileptic encephalopathies and progressive neurodegeneration 94%
- Biallelic pathogenic variants in TRMT1 disrupt tRNA modification and induce a syndromic neurodevelopmental disorder 94%
- A recurrent de novo splice site variant involving DNM1 alternative exon 10a causes developmental and epileptic encephalopathy through a dominant-negative mechanism 93%
Similar papers in this journal
- Spatial Transcriptomic Analysis of Pituitary Corticotroph Tumors Unveils Intratumor Heterogeneity 91%
- Using structural analysis in silico to assess the impact of missense variants in MEN1 91%
- In situ spatial reconstruction of distinct normal and pathological cell populations within the human adrenal gland 90%
Similar papers in this journal
- Naa12 compensates for Naa10 in mice in the amino-terminal acetylation pathway 94%
- EPHX1 mutations cause a lipoatrophic diabetes syndrome due to impaired epoxide hydrolysis and increased cellular senescence 93%
- Recessive pathogenic variants in MCAT cause combined oxidative phosphorylation deficiency 93%
Similar papers in this journal
- Advancing in Schaaf-Yang syndrome pathophysiology: from bedside to subcellular analyses of truncated MAGEL2 92%
- De novo coding variants in the AGO1 gene cause a neurodevelopmental disorder with intellectual disability 92%
- A RIPOR2 in-frame deletion is a frequent and highly penetrant cause of adult-onset hearing loss 90%
Similar papers in this journal
- Mouse models for V103I and I251L gain of function variants of the human MC4R display reduced adiposity and are not protected from a hypercaloric diet 93%
- The type 2 diabetes gene product STARD10 is a phosphoinositide binding protein that controls insulin secretory granule biogenesis 92%
- Molecular interactions of PCSK9 with an inhibitory nanobody, CAP1 and HLA-C: functional regulation of LDLR levels 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.